Endoscopic Management of Colitis-Associated Neoplasia

Nathaniel A Cohen; David T Rubin

doi:10.1016/j.giec.2022.04.002

Endoscopic Management of Colitis-Associated Neoplasia

Gastrointest Endosc Clin N Am. 2022 Oct;32(4):863-873. doi: 10.1016/j.giec.2022.04.002. Epub 2022 Sep 7.

Authors

Nathaniel A Cohen¹, David T Rubin²

Affiliations

¹ Inflammatory Bowel Disease Center, University of Chicago Medicine, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA; Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago Medicine, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA. Electronic address: Nathaniel.cohen@uchospitals.edu.
² Inflammatory Bowel Disease Center, University of Chicago Medicine, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA.

PMID: 36202521
DOI: 10.1016/j.giec.2022.04.002

Abstract

This article reviews the latest data concerning the use of advanced therapeutic techniques for endoscopically treating colitis-associated neoplastic lesions and discusses factors associated with improved outcomes.

Keywords: Colorectal cancer; Endoscopic mucosal resection; Endoscopic submucosal dissection; Endoscopy; Inflammatory bowel disease; Neoplasia.

Publication types

Review

MeSH terms

Colitis* / complications
Colitis* / surgery
Colorectal Neoplasms* / etiology
Colorectal Neoplasms* / surgery
Endoscopic Mucosal Resection* / methods
Endoscopy
Humans